A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
Jhaveri, Komal, Wang, Rui, Teplinsky, Eleonora, Chandarlapaty, Sarat, Solit, David, Cadoo, Karen, Speyer, James, D’Andrea, Gabriella, Adams, Sylvia, Patil, Sujata, Haque, Sofia, O’Neill, Tara, FriedmaVolume:
19
Language:
english
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-017-0879-5
Date:
December, 2017
File:
PDF, 1.35 MB
english, 2017